Most patients with<unk>  need only reassurance. Indeed, this<unk>  was previously referred to as "benign familial hematuria" because of its usually benign course. Angiotensin converting enzyme inhibitors have been suggested to reduce the episodes of hematuria, though controlled studies are lacking. Treating co-existing hypercalciuria and hyperuricosuria will also be helpful in reducing hematuria. The molecular basis for<unk>  has yet to be elucidated fully; however, defects in the gene encoding the a4 chain of type IV collagen have been reported in some families.
Thin basement membrane disease
Balkan endemic nephropathy
Membranous glomerulonephritis
Focal segmental glomerulosclerosis
Malarial nephropathy
Transplant glomerulopathy
Mesoamerican nephropathy
Membranoproliferative glomerulonephritis